Apixaban

Overview

Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.

Application

Products > Drug Discovery > Impurities > Cardiovascular And Blood System > Apixaban and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-069824
• CAS No.: 503612-47-3
• Molecular Formula: C25H25N5O4
• Molecular Weight: 459.506
• Purity: 0.98
• Solubility: 0.11mg/mL

Source

Original product source